Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.
Su Y, Long X, Song Y, Chen P, Li S, Yang H, Wu P, Wang Y, Bing Z, Cao Z, Cao L, Wu Y, Zhang Z, Liu J, Li B, Xiang J, Ma K, Zhang T, Zhang L, Mao X, Liu H, Xing P, Liang N.
Su Y, et al. Among authors: wu y, wu p.
Target Oncol. 2019 Apr;14(2):159-168. doi: 10.1007/s11523-019-00631-x.
Target Oncol. 2019.
PMID: 30895431